View organization detailsHide organization details
AI-first drug design and development company building a unified drug-design engine to advance new medicines.
Explore Ich jobs in blockchain and crypto. Find positions requiring Ich skills.
Daily open opportunities, newly observed postings, hiring breadth, and normalized monthly compensation for jobs in this pillar.
As of 2026-11-06
Distinct employers
-1 vs prior week
7 days vs previous 7 days
Remote pay is separated from onsite and hybrid pay so expensive cities do not distort the remote benchmark.
Remote
Limited evidence6 salaries from 2 employers
3 open jobs at 1 hiring companies
Open roles, employers, and newly listed jobs by day
Historical context; use the work-market split above for current pay
Earlier open counts are estimated from observation dates. Offline postings are never inferred open for more than 90 days; new daily samples are exact snapshots.
AI-first drug design and development company building a unified drug-design engine to advance new medicines.
AI-first drug design and development company building a unified drug-design engine to advance new medicines.
Iambic Therapeutics·1 month ago
Clinical-stage life-science and technology company that develops medicines using an AI-driven discovery and development platform.
Funding
Investors
Isomorphic Labs·1 month ago
AI-first drug design and development company building a unified drug-design engine to advance new medicines.
Iambic Therapeutics·1 month ago
Clinical-stage life-science and technology company that develops medicines using an AI-driven discovery and development platform.
Funding
Investors
Clinical-stage life-science and technology company that develops medicines using an AI-driven discovery and development platform.
Funding
Investors
Clinical-stage life-science and technology company that develops medicines using an AI-driven discovery and development platform.
Funding
Investors
Clinical-stage life-science and technology company that develops medicines using an AI-driven discovery and development platform.
Funding
Investors
AI-focused biotechnology company developing molecular-AI systems and small-molecule drug candidates for internal programs and pharmaceutical partners.